Search Results 341-350 of 9086 for 搜索引擎推荐咨询邮箱：lgooxc@hotmail.com
Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...
Learn how to request an extension for Benefactor-Funded Research Early-Career Development Awards at Mayo Clinic's Center for Clinical and Translational ...
The purpose of this study is to determine whether the combination of pevonedistat + venetoclax + azacitidine improves event-free survival (EFS) compared with ...
Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions ...
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antineoplastic activity of BLU- ...
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Learn about thyroid cancer diagnosis and treatment, including thyroid surgery, radioactive iodine and thyroid hormone therapy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.